ASK REDCHAT ANYTHING ABOUT UNICYCIVE THERAPEUTICS INC.
Unicycive Therapeutics Inc. (NASDAQ: UNCY)
Listen to this Section
$7.32
+0.0850
(
+1.18% )
322.1K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| UNI-494DetailsAcute Kidney Injury, Kidney disease |
Phase 1 |
Market Data
|
| Open |
$7.32 |
| Previous Close |
$7.23 |
| Volume |
322.1K |
| Market Cap |
$193.04M |
| Day Range |
$7.10 - $7.54 |
| 52 Week Range |
$3.71 - $11.00 |
| Shares Outstanding |
26.70M |
| Change % |
+1.18% |
| Net Change |
▲ 0.0850 |
| Insider Ownership |
-0.59% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2021 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-11,537,313.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-09-07 |
Sale |
-112147.00 |
Ryan John L |
| 2023-09-07 |
Sale |
-180000.00 |
Aggarwal Gaurav |
| 2023-08-30 |
Sale |
-1355000.00 |
Gupta Pramod |
| 2023-08-30 |
Sale |
-4684775.00 |
Gupta Shalabh K. |
| 2023-08-30 |
Sale |
-570329.00 |
Townsend John |
| 2023-08-30 |
Sale |
-1355000.00 |
Jermasek Douglas |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
14 |
Nov 12, 2025 |
| 10-q |
Quarterly Reports |
72 |
Nov 12, 2025 |
| 8-k |
8K-related |
14 |
Oct 28, 2025 |
| 4 |
Insider transactions |
1 |
Aug 26, 2025 |
| 8-k |
8K-related |
12 |
Aug 18, 2025 |
| 8-k |
8K-related |
12 |
Aug 15, 2025 |
| 10-q |
Quarterly Reports |
72 |
Aug 14, 2025 |
| 8-k |
8K-related |
14 |
Aug 14, 2025 |
| 4 |
Insider transactions |
1 |
Jul 30, 2025 |
| 4 |
Insider transactions |
1 |
Jul 30, 2025 |